Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease. Dzialas V, Bischof GN, Mollenhoff K, Drzezga A, et al. Ann Neurol 2025 Mar 27. doi: 10.1002/ana.27223.

Read + Share

Amedeo Smart

Independent Medical Education

Dzialas V, Bischof GN, Mollenhoff K, Drzezga A, et al. Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease. Ann Neurol 2025 Mar 27. doi: 10.1002/ana.27223.
PMID: 40145540